Table 2. Regions targeted for Massively Parallel Sequencing (MPS).
Targeted position (hg19) | Target gene | Targeted bases (kb) | Percentage covered (probe design) |
---|---|---|---|
chr5:33924931–33986419 | SLC45A2 | 50 | 88% |
chr6:380958–421773 | IRF4 | 41 | 95% |
chr9:12668608–12710455 | TYRP1 | 37 | 87% |
chr11:88547978–89046386 | TYR | 238 | 78% |
chr14:92755906–92967828 | SLC24A4 | 177 | 88% |
chr15:28344106–28369332 | OCA2-HERC2 | 20 | 87% |
chr15:48394145–48434879 | SLC24A5 | 39 | 95% |